$CVSI
CV Sciences, Inc.

2022 Q4 Form 10-Q Financial Statement

#000151096422000088 Filed on November 14, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3
Revenue $3.869M $3.751M
YoY Change -22.14% -26.55%
Cost Of Revenue $2.307M $2.189M
YoY Change -31.32% -20.37%
Gross Profit $1.562M $1.562M
YoY Change -2.98% -33.76%
Gross Profit Margin 40.37% 41.64%
Selling, General & Admin $3.647M $2.410M
YoY Change -63.85% -51.1%
% of Gross Profit 233.48% 154.29%
Research & Development $40.00K $44.00K
YoY Change -89.01% -89.27%
% of Gross Profit 2.56% 2.82%
Depreciation & Amortization $69.00K $63.00K
YoY Change -83.05% -81.69%
% of Gross Profit 4.42% 4.03%
Operating Expenses $3.687M $2.454M
YoY Change -64.73% -54.03%
Operating Profit -$2.125M -$892.0K
YoY Change -75.97% -70.07%
Interest Expense -$237.0K -$266.0K
YoY Change 111.61% 5220.0%
% of Operating Profit
Other Income/Expense, Net -$266.0K
YoY Change
Pretax Income -$2.362M -$1.031M
YoY Change -73.62% 2477.5%
Income Tax -$49.00K $0.00
% Of Pretax Income
Net Earnings -$2.313M -$1.031M
YoY Change -73.89% 2477.5%
Net Earnings / Revenue -59.78% -27.49%
Basic Earnings Per Share -$0.01
Diluted Earnings Per Share -$0.02 -$0.01
COMMON SHARES
Basic Shares Outstanding 150.1M shares 147.8M shares
Diluted Shares Outstanding 146.5M shares

Balance Sheet

Concept 2022 Q4 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $611.0K $1.139M
YoY Change -55.56% -31.39%
Cash & Equivalents $611.0K $1.139M
Short-Term Investments
Other Short-Term Assets $3.190M $3.143M
YoY Change 48.65% 63.78%
Inventory $6.563M $7.226M
Prepaid Expenses $3.190M
Receivables $766.0K $695.0K
Other Receivables $0.00 $0.00
Total Short-Term Assets $11.13M $12.20M
YoY Change -21.54% -14.15%
LONG-TERM ASSETS
Property, Plant & Equipment $575.0K $635.0K
YoY Change -66.51% -70.44%
Goodwill $0.00
YoY Change
Intangibles $251.0K $1.485M
YoY Change -83.1% -60.19%
Long-Term Investments
YoY Change
Other Assets $505.0K $557.0K
YoY Change -25.52% -23.7%
Total Long-Term Assets $1.606M $2.978M
YoY Change -58.61% -68.31%
TOTAL ASSETS
Total Short-Term Assets $11.13M $12.20M
Total Long-Term Assets $1.606M $2.978M
Total Assets $12.74M $15.18M
YoY Change -29.5% -35.7%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.284M $2.246M
YoY Change -12.96% 48.84%
Accrued Expenses $9.690M $9.720M
YoY Change -11.22% -10.02%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due $1.223M $1.455M
YoY Change 294.52%
Total Short-Term Liabilities $13.31M $13.54M
YoY Change -7.93% 9.94%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $188.0K $219.0K
YoY Change
Total Long-Term Liabilities $188.0K $219.0K
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $13.31M $13.54M
Total Long-Term Liabilities $188.0K $219.0K
Total Liabilities $13.51M $13.82M
YoY Change -6.95% 10.81%
SHAREHOLDERS EQUITY
Retained Earnings -$87.70M -$85.40M
YoY Change 10.35% 20.93%
Common Stock $15.00K $15.00K
YoY Change 36.36% 36.36%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$777.0K $1.365M
YoY Change
Total Liabilities & Shareholders Equity $12.74M $15.18M
YoY Change -29.5% -35.7%

Cashflow Statement

Concept 2022 Q4 2022 Q3
OPERATING ACTIVITIES
Net Income -$2.313M -$1.031M
YoY Change -73.89% 2477.5%
Depreciation, Depletion And Amortization $69.00K $63.00K
YoY Change -83.05% -81.69%
Cash From Operating Activities $210.0K -$547.0K
YoY Change -118.04% -65.11%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -738.0K 572.0K
YoY Change -183.96% 114.23%
NET CHANGE
Cash From Operating Activities 210.0K -547.0K
Cash From Investing Activities 0.000 0.000
Cash From Financing Activities -738.0K 572.0K
Net Change In Cash -528.0K 25.00K
YoY Change 85.26% -101.92%
FREE CASH FLOW
Cash From Operating Activities $210.0K -$547.0K
Capital Expenditures $0.00 $0.00
Free Cash Flow $210.0K -$547.0K
YoY Change -118.04% -65.11%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001510964
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
http://fasb.org/us-gaap/2022#ProductMember
CY2022Q3 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
http://fasb.org/us-gaap/2022#ProductMember
CY2021Q3 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
http://fasb.org/us-gaap/2022#ProductMember
us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
http://fasb.org/us-gaap/2022#ProductMember
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-54677
dei Entity Registrant Name
EntityRegistrantName
CV Sciences, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
80-0944970
dei Entity Address Address Line1
EntityAddressAddressLine1
9530 Padgett Street, Suite 107
dei Entity Address City Or Town
EntityAddressCityOrTown
San Diego
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92126
dei City Area Code
CityAreaCode
866
dei Local Phone Number
LocalPhoneNumber
290-2157
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
150104789 shares
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1139000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1375000 usd
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
695000 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2041000 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
7226000 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
8624000 usd
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3143000 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2146000 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
12203000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
14186000 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
635000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1717000 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
301000 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
0 usd
CY2022Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1485000 usd
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1485000 usd
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
557000 usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
678000 usd
CY2022Q3 us-gaap Assets
Assets
15181000 usd
CY2021Q4 us-gaap Assets
Assets
18066000 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2246000 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2624000 usd
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9720000 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
10915000 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
114000 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
0 usd
CY2022Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
0 usd
CY2021Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
612000 usd
CY2022Q3 cvsi Long Term Debt Excluding Convertible Debt Current Maturities
LongTermDebtExcludingConvertibleDebtCurrentMaturities
1455000 usd
CY2021Q4 cvsi Long Term Debt Excluding Convertible Debt Current Maturities
LongTermDebtExcludingConvertibleDebtCurrentMaturities
310000 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
13535000 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
14461000 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
219000 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 usd
CY2022Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
62000 usd
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
62000 usd
CY2022Q3 us-gaap Liabilities
Liabilities
13816000 usd
CY2021Q4 us-gaap Liabilities
Liabilities
14523000 usd
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
790000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
190000000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
150105000 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
150105000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
112482000 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
112482000 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
15000 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
11000 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
86726000 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
83007000 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-85376000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-79475000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
1365000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
3543000 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
15181000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
18066000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3751000 usd
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5107000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12336000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15079000 usd
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
2189000 usd
CY2021Q3 us-gaap Cost Of Revenue
CostOfRevenue
2749000 usd
us-gaap Cost Of Revenue
CostOfRevenue
8348000 usd
us-gaap Cost Of Revenue
CostOfRevenue
8073000 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
1562000 usd
CY2021Q3 us-gaap Gross Profit
GrossProfit
2358000 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
44000 usd
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
410000 usd
us-gaap Gross Profit
GrossProfit
3988000 usd
us-gaap Gross Profit
GrossProfit
7006000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
267000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
821000 usd
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2410000 usd
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4928000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
8443000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
15788000 usd
CY2022Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
2454000 usd
CY2021Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
5338000 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
8710000 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
16609000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-892000 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2980000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-4722000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-9603000 usd
CY2022Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
127000 usd
CY2021Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
2945000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
127000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
2945000 usd
CY2022Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-266000 usd
CY2021Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-5000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-1304000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-28000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1031000 usd
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-40000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5899000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6686000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-1031000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-40000 usd
us-gaap Net Income Loss
NetIncomeLoss
-5901000 usd
us-gaap Net Income Loss
NetIncomeLoss
-6697000 usd
CY2022Q3 cvsi Beneficial Conversion Feature Deemed Dividend Debit Credit Upon Conversion Of Preferred Stock
BeneficialConversionFeatureDeemedDividendDebitCreditUponConversionOfPreferredStock
0 usd
CY2021Q3 cvsi Beneficial Conversion Feature Deemed Dividend Debit Credit Upon Conversion Of Preferred Stock
BeneficialConversionFeatureDeemedDividendDebitCreditUponConversionOfPreferredStock
0 usd
cvsi Beneficial Conversion Feature Deemed Dividend Debit Credit Upon Conversion Of Preferred Stock
BeneficialConversionFeatureDeemedDividendDebitCreditUponConversionOfPreferredStock
920000 usd
cvsi Beneficial Conversion Feature Deemed Dividend Debit Credit Upon Conversion Of Preferred Stock
BeneficialConversionFeatureDeemedDividendDebitCreditUponConversionOfPreferredStock
0 usd
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-1031000 usd
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1031000 usd
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-40000 usd
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-40000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6821000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-6821000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-6697000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6697000 usd
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
146530000 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
146530000 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
109115000 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
109115000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
133651000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
133651000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
107099000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
107099000 shares
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
3543000 usd
CY2022Q1 us-gaap Stock And Warrants Issued During Period Value Preferred Stock And Warrants
StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
554000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
1229000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
384000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
516000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-2217000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
4009000 usd
CY2022Q2 cvsi Stock Issued During Period Value Conversion Of Preferred Shares
StockIssuedDuringPeriodValueConversionOfPreferredShares
0 usd
CY2022Q2 cvsi Beneficial Conversion Charge For Preferred Stock Conversion
BeneficialConversionChargeForPreferredStockConversion
0 usd
CY2022Q2 cvsi Shareholders Equity Deemed Dividend
ShareholdersEquityDeemedDividend
0 usd
CY2022Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
389000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
146000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-2653000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
1891000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-1031000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
1365000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
328000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
177000 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
11212000 usd
CY2021Q1 cvsi Stock Issued During Period Value Equity Commitment
StockIssuedDuringPeriodValueEquityCommitment
3222000 usd
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
657000 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-3127000 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
11964000 usd
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
0 usd
CY2021Q2 cvsi Stock Issued During Period Value Equity Commitment
StockIssuedDuringPeriodValueEquityCommitment
631000 usd
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
912000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-3530000 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
9977000 usd
CY2021Q3 cvsi Stock Issued During Period Value Equity Commitment
StockIssuedDuringPeriodValueEquityCommitment
399000 usd
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
806000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-40000 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
11142000 usd
us-gaap Net Income Loss
NetIncomeLoss
-5901000 usd
us-gaap Net Income Loss
NetIncomeLoss
-6697000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
923000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
746000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
839000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2375000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-159000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 usd
cvsi Debt Discount And Interest Expense
DebtDiscountAndInterestExpense
1300000 usd
cvsi Debt Discount And Interest Expense
DebtDiscountAndInterestExpense
0 usd
cvsi Employee Retention Credit Benefit
EmployeeRetentionCreditBenefit
2516000 usd
cvsi Employee Retention Credit Benefit
EmployeeRetentionCreditBenefit
0 usd
cvsi Noncash Lease Expense
NoncashLeaseExpense
44000 usd
cvsi Noncash Lease Expense
NoncashLeaseExpense
284000 usd
us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
0 usd
us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
906000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
127000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
2945000 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
361000 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
220000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1172000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
695000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1398000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
36000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1483000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-916000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1230000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
417000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2095000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6321000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
35000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-236000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2865000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3491000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-35000 usd
cvsi Proceeds From Issuance Of Preferred Stock And Common Stock Warrants Net Of Issuance Costs
ProceedsFromIssuanceOfPreferredStockAndCommonStockWarrantsNetOfIssuanceCosts
554000 usd
cvsi Proceeds From Issuance Of Preferred Stock And Common Stock Warrants Net Of Issuance Costs
ProceedsFromIssuanceOfPreferredStockAndCommonStockWarrantsNetOfIssuanceCosts
0 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
954000 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
1577000 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4212000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4212000 usd
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
675000 usd
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
0 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
240000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
0 usd
us-gaap Repayments Of Unsecured Debt
RepaymentsOfUnsecuredDebt
311000 usd
us-gaap Repayments Of Unsecured Debt
RepaymentsOfUnsecuredDebt
721000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1859000 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1660000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1375000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4525000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1139000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
4000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
7000 usd
cvsi Increase Decrease In Convertible Note
IncreaseDecreaseInConvertibleNote
-1284000 usd
cvsi Increase Decrease In Convertible Note
IncreaseDecreaseInConvertibleNote
0 usd
cvsi Services Paid With Common Stock
ServicesPaidWithCommonStock
384000 usd
cvsi Services Paid With Common Stock
ServicesPaidWithCommonStock
0 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
345000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 segment
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2100000 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7500000 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-85400000 usd
CY2022Q1 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
700000 usd
cvsi Cares Act Tax Credit Received Under Relief Provision
CARESActTaxCreditReceivedUnderReliefProvision
2500000 usd
us-gaap Use Of Estimates
UseOfEstimates
<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The preparation of the condensed financial statements in conformity with U.S. GAAP requires management to make judgments, estimates and assumptions that affect the reported amounts in the condensed financial statements and accompanying notes. Actual results may differ from these estimates. Significant estimates include the valuation of intangible assets, inputs for valuing equity awards, valuation of inventory and assumptions related to revenue recognition.</span>
CY2022Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
0 usd
CY2021Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
0 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3751000 usd
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5107000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12336000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15079000 usd
us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P5Y
CY2021Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
4023000 usd
CY2022Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
3698000 usd
CY2022Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
1221000 usd
CY2021Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
1286000 usd
CY2022Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2307000 usd
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
3315000 usd
CY2022Q3 us-gaap Inventory Gross
InventoryGross
7226000 usd
CY2021Q4 us-gaap Inventory Gross
InventoryGross
8624000 usd
CY2022Q3 us-gaap Inventory Write Down
InventoryWriteDown
100000 usd
us-gaap Inventory Write Down
InventoryWriteDown
300000 usd
CY2021Q3 us-gaap Inventory Write Down
InventoryWriteDown
100000 usd
us-gaap Inventory Write Down
InventoryWriteDown
200000 usd
CY2022Q3 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
8467000 usd
CY2021Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
9023000 usd
CY2022Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1253000 usd
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1892000 usd
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9720000 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
10915000 usd
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
300000 usd
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
400000 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
300000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
0 usd
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
0 usd
CY2022Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P32M
CY2022Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.070
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
33000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
135000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
139000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
60000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
367000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
34000 usd
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
333000 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
114000 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
219000 usd
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
333000 usd
CY2022Q2 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
151772 usd
CY2022Q2 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
3751971 shares
CY2022Q2 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.04
CY2022Q3 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
10149785 shares
us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
24126311 shares
us-gaap Interest Expense Debt
InterestExpenseDebt
600000 usd
CY2022Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
127000 usd
CY2022Q3 us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
50000 usd
CY2022Q3 cvsi Long Term Debt Excluding Convertible Debt Current Maturities
LongTermDebtExcludingConvertibleDebtCurrentMaturities
1455000 usd
CY2021Q4 cvsi Long Term Debt Excluding Convertible Debt Current Maturities
LongTermDebtExcludingConvertibleDebtCurrentMaturities
310000 usd
cvsi Caresact Proceeds To Be Remitted To Lender Minimum
CARESACTProceedsToBeRemittedToLenderMinimum
1000000 usd
CY2022Q2 us-gaap Capital Units Authorized
CapitalUnitsAuthorized
200000000 shares
CY2022Q2 us-gaap Capital Units Authorized
CapitalUnitsAuthorized
800000000 shares
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
190000000 shares
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
790000000 shares
CY2022Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
10000000 shares
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q1 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
700000 usd
CY2022Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
600000 usd
CY2022Q1 cvsi Sale Of Stock Deduction From Proceeds Related To Agents Fees And Other Offering Expenses
SaleOfStockDeductionFromProceedsRelatedToAgentsFeesAndOtherOfferingExpenses
100000 usd
CY2022Q1 cvsi Preferred Stock Par Or Stated Value Per Share Subjected To Conversion
PreferredStockParOrStatedValuePerShareSubjectedToConversion
1000
CY2022Q1 us-gaap Preferred Stock Convertible Shares Issuable
PreferredStockConvertibleSharesIssuable
10000000 shares
CY2022Q1 us-gaap Preferred Stock Convertible Conversion Price
PreferredStockConvertibleConversionPrice
0.07
CY2022Q1 cvsi Class Of Warrants Or Rights Fair Value Recorded As Additional Offering Cost
ClassOfWarrantsOrRightsFairValueRecordedAsAdditionalOfferingCost
100000 usd
CY2022Q1 us-gaap Preferred Stock Convertible Shares Issuable
PreferredStockConvertibleSharesIssuable
10000000 shares
cvsi Preferred Stock Convertible Beneficial Conversion Charge
PreferredStockConvertibleBeneficialConversionCharge
900000 usd
CY2022Q1 cvsi Preferred Stock Number Of Votes Per Share
PreferredStockNumberOfVotesPerShare
170000 vote
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
200000000 shares
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
800000000 shares
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
190000000 shares
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
790000000 shares
CY2022Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
10750000 shares
CY2021Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
0 shares
CY2022Q1 cvsi Share Based Compensation Arrangement By Share Based Payment Award Increase Decrease In Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseDecreaseInNumberOfSharesAuthorized
8000000 shares
CY2022Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
400000 usd
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P0Y4M24D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.200
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.200
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.337
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.030
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.030
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.009
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y6M7D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y6M7D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y7M9D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.03
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.03
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.49
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
36918000 shares
CY2021Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
39141000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
36918000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
39141000 shares
CY2021Q2 cvsi Numberof Derivative Lawsuits
NumberofDerivativeLawsuits
5 lawsuit
CY2022Q2 cvsi Loss Contingency Issuance Of Interim Awarding Related To Purchase Of Psl And Other Advance Payments
LossContingencyIssuanceOfInterimAwardingRelatedToPurchaseOfPSLAndOtherAdvancePayments
300000 usd
CY2022Q2 cvsi Termination Severance And Other Post Termination Compensation And Benefits Under His Employment Agreement
TerminationSeveranceAndOtherPostTerminationCompensationAndBenefitsUnderHisEmploymentAgreement
600000 usd
CY2022Q3 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
300000 usd
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 segment
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3751000 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
1562000 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
44000 usd
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2410000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-892000 usd
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5107000 usd
CY2021Q3 us-gaap Gross Profit
GrossProfit
2358000 usd
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
410000 usd
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4928000 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2980000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12336000 usd
us-gaap Gross Profit
GrossProfit
3988000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
267000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
8443000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-4722000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15079000 usd
us-gaap Gross Profit
GrossProfit
7006000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
821000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
15788000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-9603000 usd
CY2021Q3 cvsi Net Operating Loss Tax Benefit Recognized
NetOperatingLossTaxBenefitRecognized
0 usd
CY2022Q3 cvsi Net Operating Loss Tax Benefit Recognized
NetOperatingLossTaxBenefitRecognized
0 usd
cvsi Net Operating Loss Tax Benefit Recognized
NetOperatingLossTaxBenefitRecognized
0 usd
cvsi Net Operating Loss Tax Benefit Recognized
NetOperatingLossTaxBenefitRecognized
0 usd
CY2020 cvsi Employee Portion Of Payroll Taxes Paid
EmployeePortionOfPayrollTaxesPaid
200000 usd

Files In Submission

Name View Source Status
0001510964-22-000088-index-headers.html Edgar Link pending
0001510964-22-000088-index.html Edgar Link pending
0001510964-22-000088.txt Edgar Link pending
0001510964-22-000088-xbrl.zip Edgar Link pending
cvsi-20220930.htm Edgar Link pending
cvsi-20220930.xsd Edgar Link pending
cvsi-20220930xex311.htm Edgar Link pending
cvsi-20220930xex312.htm Edgar Link pending
cvsi-20220930xex321.htm Edgar Link pending
cvsi-20220930xex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
cvsi-20220930_def.xml Edgar Link unprocessable
cvsi-20220930_lab.xml Edgar Link unprocessable
cvsi-20220930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
cvsi-20220930_htm.xml Edgar Link completed
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
cvsi-20220930_cal.xml Edgar Link unprocessable